Nano-X Imaging Ltd. (NNOX) Fair Value 2026

NNOX · Medical Devices ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

5.6 /10

32 fundamental signals · 1 models active

Value Trap Risk

SAFE (14/100)

Quick Summary — As of 2026-08-28, Nano-X Imaging Ltd. (NNOX) trades at $0.83. QOC: 5.6/10. Value Trap Risk: 14/100 (SAFE). 1/13 models active.

Key Facts

Ticker
NNOX
Price
$0.83
Quality Score
5.6/10
Value Trap Risk
14/100
Models Active
1/13
Last Updated
Strength: Dynamic NAV suggests +71.2% upside with 46% confidence
Risk: Limited model coverage (1/13) may reduce confidence

What Fair Value Does Each Model Give NNOX?

1 Intrinsic Value Models vs. Current Price ($0.83)

Core Models (Unlocked)
Model Fair Value Upside
Asset-Based · Medium Conviction
 $1.42 +71.2%

All Models Active

All 1 models are displayed above.

What Is Nano-X Imaging Ltd. (NNOX) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Nano-X Imaging Ltd. is potentially undervalued at its current price of $0.83. Based on our 13-model framework, Nano-X Imaging Ltd.'s intrinsic value is estimated at a median fair value of $1.42 — representing +71.2% implied upside — with 1 out of 1 active models confirming this thesis.

What Do the Models Say About NNOX?

1 of 13 models are currently active for NNOX. All 1 active models suggest the stock trades below fair value. See which stocks rank higher →

How Does NNOX Rank in Medical Devices?

Among 159 Medical Devices stocks, NNOX ranks #107 by Quality of Company score. CirclFi's QOC score of 5.6/10 evaluates 32 fundamental signals. A score of 5.6 reflects mixed fundamentals.

See all Most Undervalued Medical Devices Stocks →

Within the Medical Devices space, Nano-X Imaging Ltd. competes in an environment where patent cliff exposure often separates market leaders from laggards. Understanding these industry-specific dynamics is essential context for interpreting our model outputs.

Is NNOX a Value Trap?

CirclFi's Value Trap algorithm assigns NNOX a score of 14/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

1 of 13 models are active for Nano-X Imaging Ltd.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, Nano-X Imaging Ltd. is rated at 5.6/10. This solid-tier score maintains reasonable quality metrics with some areas for improvement.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every NNOX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across NNOX's 1 active models, average confidence is 46%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Nano-X Imaging Ltd. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Devices Stocks Should You Also Analyze?

11 related Medical Devices stocks with 13-model coverage

QTIQT Imaging Holdings, Inc.QOC 5.6LFWDLifeward Ltd.QOC 5.6SINTSintx Technologies, Inc.QOC 5.7PACBPacific Biosciences of California, Inc.QOC 5.6BMRABiomerica, Inc.QOC 5.7COCHEnvoy Medical, Inc.QOC 5.6PFSAProfusa, Inc.QOC 4.1VMDViemed Healthcare, Inc.QOC 8.2SERASera Prognostics, Inc.QOC 6.6IRMDIRADIMED CORPORATIONQOC 9.8PODDInsulet CorporationQOC 9.6

Read investment analysis: QTI · LFWD · SINT · PACB · BMRA · COCH · PFSA · VMD · SERA · IRMD · PODD

Which Other Stocks Have a Similar Quality Score to NNOX?

5 companies across all industries closest to NNOX’s Quality of Company score of 5.6/10.

CYCNCyclerion Therapeutics, Inc.QOC 5.6KLARKlarna Group plcQOC 5.6ABATAmerican Battery Technology CompanyQOC 5.6FATEFate Therapeutics, Inc.QOC 5.6NVDANVIDIA CorporationQOC 10.0

Read investment analysis: CYCN · KLAR · ABAT · FATE · NVDA

Where Does NNOX Sit in CirclFi's Medical Devices Rankings?

NNOX is ranked against every other Medical Devices stock CirclFi covers in each of these screens.

See all Medical Devices stocks ranked →

What Else Do Investors Ask About Nano-X Imaging Ltd.’s Valuation?

What is Nano-X Imaging Ltd.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for Nano-X Imaging Ltd. (NNOX). The Quality of Company score is 5.6/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is NNOX overvalued or undervalued right now?

At $0.83, 1 of 1 active models suggest NNOX may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits Nano-X Imaging Ltd.'s business model in Medical Devices.

What does a Quality of Company score of 5.6 mean for NNOX?

Nano-X Imaging Ltd.'s QOC of 5.6/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on NNOX?

CirclFi analyzes NNOX with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 1 of 13 are active for this stock. Read the full methodology →

Is NNOX a value trap in 2026?

Nano-X Imaging Ltd.'s Value Trap score is 14/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns Nano-X Imaging Ltd. (NNOX) a Quality of Company score of 5.6/10 across 32 fundamental signals as of 2026-08-28.” Source: circlfi.com/stock/NNOX/ · Methodology
Primary sources for this NNOX valuation
  • Financial statements: Nano-X Imaging Ltd. 10-K and 10-Q filings on SEC EDGAR (CIK 0001795251) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for NNOX as of ; valuations recomputed .